Melatonin versus placebo in the prophylaxis of cluster headache: A double-blind pilot study with parallel groups

M. Leone, D. D'Amico, F. Moschiano, F. Fraschini, G. Bussone

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

A fall in nocturnal plasma melatonin occurs in patients with cluster headache, suggesting that melatonin may play a role in the promotion of attacks. During a cluster period, we administered melatonin to 20 cluster headache patients (2 primary chronic, 18 episodic) in a double-blind placebo-controlled study of oral melatonin 10 mg (n=10) or placebo (n=10) for 14 days taken in a single evening dose. Headache frequency was significantly reduced (ANOVA, p

Original languageEnglish
Pages (from-to)494-496
Number of pages3
JournalCephalalgia
Volume16
Issue number7
DOIs
Publication statusPublished - 1996

Fingerprint

Cluster Headache
Melatonin
Double-Blind Method
Placebos
Headache
Analysis of Variance

Keywords

  • Cluster headache
  • Melatonin
  • Pathogenesis
  • Prophylaxis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Melatonin versus placebo in the prophylaxis of cluster headache : A double-blind pilot study with parallel groups. / Leone, M.; D'Amico, D.; Moschiano, F.; Fraschini, F.; Bussone, G.

In: Cephalalgia, Vol. 16, No. 7, 1996, p. 494-496.

Research output: Contribution to journalArticle

@article{91b5c51c4f78489f9aa7ae0b2805453c,
title = "Melatonin versus placebo in the prophylaxis of cluster headache: A double-blind pilot study with parallel groups",
abstract = "A fall in nocturnal plasma melatonin occurs in patients with cluster headache, suggesting that melatonin may play a role in the promotion of attacks. During a cluster period, we administered melatonin to 20 cluster headache patients (2 primary chronic, 18 episodic) in a double-blind placebo-controlled study of oral melatonin 10 mg (n=10) or placebo (n=10) for 14 days taken in a single evening dose. Headache frequency was significantly reduced (ANOVA, p",
keywords = "Cluster headache, Melatonin, Pathogenesis, Prophylaxis",
author = "M. Leone and D. D'Amico and F. Moschiano and F. Fraschini and G. Bussone",
year = "1996",
doi = "10.1046/j.1468-2982.1996.1607494.x",
language = "English",
volume = "16",
pages = "494--496",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Melatonin versus placebo in the prophylaxis of cluster headache

T2 - A double-blind pilot study with parallel groups

AU - Leone, M.

AU - D'Amico, D.

AU - Moschiano, F.

AU - Fraschini, F.

AU - Bussone, G.

PY - 1996

Y1 - 1996

N2 - A fall in nocturnal plasma melatonin occurs in patients with cluster headache, suggesting that melatonin may play a role in the promotion of attacks. During a cluster period, we administered melatonin to 20 cluster headache patients (2 primary chronic, 18 episodic) in a double-blind placebo-controlled study of oral melatonin 10 mg (n=10) or placebo (n=10) for 14 days taken in a single evening dose. Headache frequency was significantly reduced (ANOVA, p

AB - A fall in nocturnal plasma melatonin occurs in patients with cluster headache, suggesting that melatonin may play a role in the promotion of attacks. During a cluster period, we administered melatonin to 20 cluster headache patients (2 primary chronic, 18 episodic) in a double-blind placebo-controlled study of oral melatonin 10 mg (n=10) or placebo (n=10) for 14 days taken in a single evening dose. Headache frequency was significantly reduced (ANOVA, p

KW - Cluster headache

KW - Melatonin

KW - Pathogenesis

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=0029827884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029827884&partnerID=8YFLogxK

U2 - 10.1046/j.1468-2982.1996.1607494.x

DO - 10.1046/j.1468-2982.1996.1607494.x

M3 - Article

C2 - 8933994

AN - SCOPUS:0029827884

VL - 16

SP - 494

EP - 496

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 7

ER -